2m 2m 2m 2m 2m 2m 2m
BIOVENTUS-A (BVS)
NASDAQ
$9.50+$0.21 (+2.25%)
Price as of Jun 23, 2026 7:59 PM EDT- $595.5MMarket Cap
- 37.43%1-Year Change
- Medical DevicesIndustry
BIOVENTUS-A (BVS)
$9.50+$0.21 (+2.25%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 568.1M -0.91% | 573.3M +11.89% | 512.3M +0.04% | 512.1M +18.85% | |
Cost of Revenue | 179.9M -2.77% | 185.1M +0.49% | 184.2M +1.72% | 181.0M +41.22% | |
Gross Profit | 388.2M -0.02% | 388.2M +18.29% | 328.2M -0.87% | 331.1M +9.37% | |
Sales and Marketing Expense | 314.0M -7.88% | 340.9M +12.18% | 303.9M -8.64% | 332.6M +30.82% | |
Research and Development Expense | -12.1M -11.19% | -13.6M +1.44% | -13.4M -151.83% | 25.9M +36.25% | |
Depreciation and Amortization Expense | 47.0M -5.13% | 49.6M -13.61% | 57.4M -14.13% | 66.8M +91.55% | |
Total Operating Expenses | 179.9M -2.77% | 185.1M +0.49% | 184.2M +1.72% | 181.0M +41.22% | |
Operating Profit | 54.0M +550.58% | -12.0M -85.34% | -81.7M -67.45% | -251.0M -2,181.49% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -26.5M -31.72% | -38.8M -4.63% | -40.7M +57.69% | -25.8M +2,219.69% | |
Interest Income and Expense and Net | -26.5M -31.72% | -38.8M -4.63% | -40.7M +57.69% | -25.8M +2,219.69% | |
Total Nonoperating Income and Expense | -28.3M -23.91% | -37.1M -5.68% | -39.4M +206.48% | -12.9M +189.37% | |
Income before Taxes | 25.7M +152.33% | -49.1M -59.44% | -121.1M -54.11% | -263.9M -3,563.24% | |
Income Taxes | -1.6M -70.43% | -5.3M -6,327.06% | 85,000 +100.17% | -50.5M +2,469.07% | |
Extraordinary Items | 0 -100.00% | 36.4M -53.75% | 78.6M -60.59% | 199.5M +3,415.72% | |
Net Income | 22.7M +167.77% | -33.5M -78.53% | -156.2M -1.56% | -158.7M -919.12% | |
Net Income from Continuing Operations Applicable to Common | 25.7M +152.33% | -49.1M -59.44% | -121.1M -54.11% | -263.9M -3,563.24% | |
Basic EPS and Net Income | 0.34 +165.38% | -0.52 -79.12% | -2.49 -3.86% | -2.59 +1,626.67% | |
Diluted EPS and Net Income | 0.33 +163.46% | -0.52 -79.12% | -2.49 -3.86% | -2.59 +1,626.67% | |
Basic Weighted Average Shares | 66.6M +3.21% | 64.5M +3.03% | 62.6M +2.05% | 61.4M +35.00% | |
Diluted Weighted Average Shares | 68.9M +6.77% | 64.5M +3.03% | 62.6M +2.05% | 61.4M +35.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 51.2M +23.22% | 41.6M +12.49% | 37.0M +16.19% | 31.8M -27.59% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 51.2M +23.22% | 41.6M +12.49% | 37.0M +16.19% | 31.8M -27.59% | |
Total Current Assets | 272.8M -1.00% | 275.6M +2.84% | 268.0M -1.68% | 272.6M +3.60% | |
Accumulated Depreciation | 54.3M +8.13% | 50.2M +64,241.03% | 78,000 -99.75% | 30.9M +33.65% | |
Property and Plant and Equipment and Net | 21.9M -18.93% | 27.0M -26.21% | 36.6M +32.40% | 27.6M +20.28% | |
Total Long-Term Assets | N/A N/A | N/A N/A | N/A N/A | 27.6M +20.28% | |
Total Assets | 683.6M -6.10% | 728.0M -10.23% | 810.9M -40.92% | 1.4B +11.97% | |
Income Taxes Payable | 433,000 -23.23% | 564,000 -53.50% | 1.2M -99.21% | 154.0M +15.34% | |
Total Short-Term Debt | 15.0M -45.13% | 27.3M -1.83% | 27.8M -15.76% | 33.1M +83.26% | |
Total Current Liabilities | 160.4M -23.77% | 210.4M +19.89% | 175.5M -42.27% | 304.0M +68.10% | |
Total Long-Term Debt | 279.0M -9.52% | 308.3M -16.00% | 367.0M -4.68% | 385.0M +13.36% | |
Total Long-Term Liabilities | 15.3M -33.56% | 23.1M -17.30% | 27.9M +10.25% | 25.3M +16.64% | |
Total Liabilities | 455.1M -16.09% | 542.4M -8.04% | 589.8M -42.87% | 1.0B +49.16% | |
Retained Earnings | -334.9M -5.67% | -355.1M +10.43% | -321.5M +94.51% | -165.3M +2,403.88% | |
Total Stockholders Equity | 184.1M +24.45% | 147.9M -14.78% | 173.6M -45.17% | 316.6M -31.02% | |
Total Shares Outstanding | 67.1M -58.86% | 163.1M +3.15% | 158.1M N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | 74.7M +92.48% | 38.8M +152.83% | 15.3M +213.35% | -13.5M -158.88% | |
Capital Expenditures | 2.6M +154.67% | 1.0M -86.34% | 7.4M -26.69% | 10.0M +36.26% | |
Cash from Investing Activities | -3.2M -114.14% | 23.0M +45.27% | 15.8M +113.58% | -116.4M -58.97% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -62.1M +13.85% | -54.6M +104.78% | -26.7M -142.94% | 62.1M -77.29% | |
Financials Ratio | |||||
Gross Margin | 68.33% +0.90% | 67.72% +5.72% | 64.06% -0.92% | 64.65% N/A | |
Operating Margin | 9.50% +554.69% | -2.09% -86.90% | -15.95% -67.46% | -49.02% N/A | |
Return on Assets | 3.22% +173.89% | -4.36% -69.54% | -14.31% +17.15% | -12.21% N/A | |
Return on Equity | 13.69% +165.63% | -20.86% -67.27% | -63.74% +55.74% | -40.93% N/A | |
Revenue Growth | -0.91% -107.62% | 11.89% +26,626.74% | 0.04% -99.76% | 18.85% N/A | |
Current Ratio | 1.70 +29.87% | 1.31 -14.22% | 1.53 +70.32% | 0.90 N/A | |
Cash Ratio | 0.32 +61.69% | 0.20 -6.17% | 0.21 +101.34% | 0.10 N/A | |
Debt-to-Equity Ratio | 1.60 -29.62% | 2.27 -0.26% | 2.27 +72.24% | 1.32 N/A | |
Debt-to-Assets Ratio | 0.43 -6.74% | 0.46 -5.30% | 0.49 +59.85% | 0.30 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow